ReviewCureus2026
Dietary Strategies for Gut Barrier Integrity in Inflammatory Bowel Disease: The Impact of Fiber and Beyond.
Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dietary fiber is increasingly viewed as a promising adjunct in inflammatory bowel disease (IBD) management due to its potential to support gut barrier function, shape the intestinal microbiota, and influence inflammatory pathways, yet many patients restrict fiber during flares and remission to reduce symptoms despite uncertainty about the long-term consequences of such avoidance. This narrative review synthesizes mechanistic, clinical, and real-world evidence on dietary fiber characteristics, tolerability, and associations with IBD outcomes, with attention to how fiber quality and intake context vary across patient groups. Overall, available findings suggest that adequate, appropriately selected fiber may contribute to gut homeostasis and symptom control, but substantial gaps persist regarding the most suitable fiber types, effective amounts, and practical food sources that balance benefit with tolerability. Although guidance increasingly favors maintaining adequate fiber intake when feasible, more rigorous, patient-centered intervention studies and improved characterization of real-world intake patterns are needed to enable personalized recommendations and safe integration of fiber-rich foods into individualized care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.